Managed by Gsk Plc • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| — |
| 5 | L LYEL — | $46.6M | 1.51M | 0.00% | — |
| 6 | I IDYA — | $46.1M | 1.33M | 0.00% | — |
| 7 | C CYTK — | $21.6M | 340.4K | 0.00% | — |
| 8 | S SPRO — | $21.4M | 9.19M | 0.00% | — |
| 9 | F FULC — | $20.2M | 1.79M | 0.00% | — |
| 10 | B BCYC — | $10.8M | 1.53M | 0.00% | — |
| 11 | C CVRX — | $7.2M | 1.01M | 0.00% | — |
| 12 | N NKTX — | $5.8M | 3.15M | 0.00% | — |
| 13 | R RGNX — | $3.9M | 271.5K | 0.00% | — |
| 14 | S SENS — | $60K | 10.9K | 0.00% | — |
| 15 | H HBIO — | $7K | 11.2K | 0.00% | — |